Trial intelligence / Profile preview

DARINA pilot study in thromboprophylaxis after total knee arthroplasty

2011-003556-39Phase 3Active

Sponsor
Martini Ziekenhuis
Start
May 2012
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial in venous thromboembolism (VTE) comparing dabigatran etexilate arm, rivaroxaban arm and nadroparin arm (3 arms). Primary endpoint: Clinical safety. Started May 2012; status: active.

02

Drugs

dabigatranrivaroxabannadroparin
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on 2011-003556-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003556-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call